The prevention of colorectal cancer by aspirin use. (Q33725865)

28 July 2017

1 reference

title

The prevention of colorectal cancer by aspirin use. (English)

1 reference

28 July 2017

1 reference

1 reference

1 reference

Giovannucci E

1

1 reference

28 July 2017

1 August 1999

1 reference

Biomedicine and Pharmacotherapy

28 July 2017

1 reference

28 July 2017

53

1 reference

28 July 2017

303-308

1 reference

28 July 2017

7

1 reference

Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin inhibits phospholipase C

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Effects of aspirin on 1, 2-dimethylhydrazine-induced colonic carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin use and p53 expression in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Low-dose aspirin and incidence of colorectal tumors in a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Sulindac treatment for familial polyposis coli

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Incidence of Cancer Among Patients With Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Effects of sulindac on sporadic colorectal adenomatous polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Diseases preceding colon cancer. A case-control study among veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Nonsteroidal antiinflammatory drugs and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

The evolution of cancer of the colon and rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin use and chronic diseases: a cohort study of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Treatment of Chemically-Induced Intestinal Cancers with Indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Inhibiting intracellular signalling as a strategy for cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Effects of Long-term Sulindac Therapy on Colonic Polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin use, cancer, and polyps of the large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Sulindac for polyposis of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

Sulindac for polyposis of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988500-5

7 January 2021

10.1016/S0753-3322(00)88500-5

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10472428